Polymorph forms

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9499543
APP PUB NO 20160083381A1
SERIAL NO

14890678

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel crystal forms of 2-amino-N-[2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo-ethyl]-isobutyramide L-tartrate. More particularly, the invention relates to polymorph forms, and to processes for the preparation of compositions containing and to uses of such polymorph forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RAQUALIA PHARMA INC1-21-19 MEIEKI MINAMI NAKAMURA-KU NAGOYA-SHI AICHI 4500003

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Numata, Toyoharu Aichi, JP 11 58
Shimada, Kaoru Aichi, JP 30 93
Sudo, Masaki Aichi, JP 18 26
Wakabayashi, Hiroaki Aichi, JP 33 240

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00